112 related articles for article (PubMed ID: 35249342)
1. Risk factors and correlation of colorectal polyps with type 2 diabetes mellitus.
Xu J; He W; Zhang N; Sang N; Zhao J
Ann Palliat Med; 2022 Feb; 11(2):647-654. PubMed ID: 35249342
[TBL] [Abstract][Full Text] [Related]
2. Clinical Features and Microvascular Complications Risk Factors of Early-onset Type 2 Diabetes Mellitus.
Huang JX; Liao YF; Li YM
Curr Med Sci; 2019 Oct; 39(5):754-758. PubMed ID: 31612393
[TBL] [Abstract][Full Text] [Related]
3. Diabetes mellitus and hyperglycemia control on the risk of colorectal adenomatous polyps: a retrospective cohort study.
Budzynska K; Passerman D; White-Perkins D; Rees DA; Xu J; Lamerato L; Schooley S
BMC Fam Pract; 2018 Aug; 19(1):145. PubMed ID: 30157768
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus].
Guo M; Xi G; Yang N; Yao H
Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):631-5. PubMed ID: 25243967
[TBL] [Abstract][Full Text] [Related]
5. The association of elevated HbA1c on the behavior of adenomatous polyps in patients with type-II diabetes mellitus.
Siddiqui AA; Maddur H; Naik S; Cryer B
Dig Dis Sci; 2008 Apr; 53(4):1042-7. PubMed ID: 17939046
[TBL] [Abstract][Full Text] [Related]
6. Increased plasma osteopontin levels are associated with nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
Wang C; He M; Peng J; Li S; Long M; Chen W; Liu D; Yang G; Zhang L
Cytokine; 2020 Jan; 125():154837. PubMed ID: 31514105
[TBL] [Abstract][Full Text] [Related]
7. Correlations between blood uric acid and the incidence and progression of type 2 diabetes nephropathy.
Li GX; Jiao XH; Cheng XB
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):506-511. PubMed ID: 29424910
[TBL] [Abstract][Full Text] [Related]
8. Fluctuation between fasting and 2-H postload glucose state is associated with chronic kidney disease in previously diagnosed type 2 diabetes patients with HbA1c ≥ 7%.
Wang C; Song J; Ma Z; Yang W; Li C; Zhang X; Hou X; Sun Y; Lin P; Liang K; Gong L; Wang M; Liu F; Li W; Yan F; Yang J; Wang L; Tian M; Liu J; Zhao R; Chen L
PLoS One; 2014; 9(7):e102941. PubMed ID: 25047354
[TBL] [Abstract][Full Text] [Related]
9. [The clinical application of glycosylated hemoglobin A1c and glycated albumin values in cirrhosis patients with hyperglycemia].
Shao F; Li Q; Jia W
Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):506-10. PubMed ID: 26359011
[TBL] [Abstract][Full Text] [Related]
10. The possible correlation between serum GRB2 levels and carotid atherosclerosis in patients with type 2 diabetes mellitus.
Dong Y; Liu J; Ma J; Quan J; Bao Y; Cui Y
Front Endocrinol (Lausanne); 2022; 13():963191. PubMed ID: 36176460
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between insulin resistance, serum VCAM-1, FGF19, IGF-1 and colorectal polyps].
Qin M; Wang HP; Song B; Sun YL; Wang DY; Chen M; Shi HX; Zhang H; Li ZJ
Zhonghua Zhong Liu Za Zhi; 2021 May; 43(5):553-562. PubMed ID: 34034475
[No Abstract] [Full Text] [Related]
12. Serum Uric Acid Levels were Dynamically Coupled with Hemoglobin A1c in the Development of Type 2 Diabetes.
Wei F; Chang B; Yang X; Wang Y; Chen L; Li WD
Sci Rep; 2016 Jun; 6():28549. PubMed ID: 27328642
[TBL] [Abstract][Full Text] [Related]
13. Korean type 2 diabetes patients have multiple adenomatous polyps compared to non-diabetic controls.
Suh S; Kang M; Kim MY; Chung HS; Kim SK; Hur KY; Kim JH; Lee MS; Lee MK; Kim KW
J Korean Med Sci; 2011 Sep; 26(9):1196-200. PubMed ID: 21935276
[TBL] [Abstract][Full Text] [Related]
14. The Risk Factor Analysis for Type 2 Diabetes Mellitus Patients with Nonalcoholic Fatty Liver Disease and Positive Correlation with Serum Uric Acid.
Li YL; Xie H; Musha H; Xing Y; Mei CX; Wang HJ; Wulasihan M
Cell Biochem Biophys; 2015 Jul; 72(3):643-7. PubMed ID: 27352181
[TBL] [Abstract][Full Text] [Related]
15. Serum uric acid in relation to serum 1,5-anhydroglucitol levels in patients with and without type 2 diabetes mellitus.
Ouchi M; Oba K; Aoyama J; Watanabe K; Ishii K; Yano H; Motoyama M; Sekimizu K; Matsumura N; Igari Y; Suzuki T; Nakano H
Clin Biochem; 2013 Oct; 46(15):1436-41. PubMed ID: 23778057
[TBL] [Abstract][Full Text] [Related]
16. Association between serum HbA1c levels and adenomatous polyps in patients with the type 2 diabetes mellitus.
Huang X; Fan Y; Zhang H; Wu J; Zhang X; Luo H
Minerva Endocrinol; 2015 Sep; 40(3):163-7. PubMed ID: 25003225
[TBL] [Abstract][Full Text] [Related]
17. The Relationship between Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Measured by Controlled Attenuation Parameter.
Chon YE; Kim KJ; Jung KS; Kim SU; Park JY; Kim do Y; Ahn SH; Chon CY; Chung JB; Park KH; Bae JC; Han KH
Yonsei Med J; 2016 Jul; 57(4):885-92. PubMed ID: 27189281
[TBL] [Abstract][Full Text] [Related]
18. Increased Circulating Levels of Ectodysplasin A in Newly Diagnosed Type 2 Diabetic Patients.
Deng X; Cai Z; Li Y; Wu X; Zhao L; Li H; Chen K; Zhang P; Wang C; Zhao Z; Yang L; Yuan G
Front Endocrinol (Lausanne); 2021; 12():737624. PubMed ID: 34858327
[TBL] [Abstract][Full Text] [Related]
19. Atherogenic Index of Plasma is Associated with Body Fat Level in Type 2 Diabetes Mellitus Patients.
Song P; Xu L; Xu J; Zhang HQ; Yu CX; Guan QB; Zhao M; Zhang X
Curr Vasc Pharmacol; 2018; 16(6):589-595. PubMed ID: 29299987
[TBL] [Abstract][Full Text] [Related]
20. Correlation of blood glucose, serum chemerin and insulin resistance with NAFLD in patients with type 2 diabetes mellitus.
Zhang Z; Wang J; Wang H
Exp Ther Med; 2018 Mar; 15(3):2936-2940. PubMed ID: 29456698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]